PIK3CD and breast cancer: For example, approximately 30% of breast cancers demonstrated activating missense mutations of PIK3CA, the gene encoding the catalytic p110α subunit of class I PI3K, and the mutated gene provides cells with a growth advantage and promotes tumorigenesis [13].